Skip to main content
. 2022 Jan 20;13:20406207211072838. doi: 10.1177/20406207211072838

Figure 2.

Figure 2.

Response rate of MDR-aGVHD patients after MSCs treatment. Patients are grouped by (a) severity of aGVHD; (b) site of aGVHD; (c) number of involved sites; (d) number of treatments before MSCs treatment.